Manifest Technologies
Manifest Technologies has created the NAIO™ (Neuroscience and Artificial Intelligence Optimized) platform, which enables automated integration, processing, and analysis of large, complex neuroimaging data sets. The company aims to transform therapeutic development, diagnosis, and treatment for CNS disorders by advancing the world's first AI-powered computational neuroimaging system that quantifies neural and symptom data to create and choose the right therapy for the right patient at the right time. With over $50M in NIMH grants supporting their validated science, they focus on biomarker discovery, pharmacological target validation, and patient selection for CNS clinical trials.
Manifest Technologies
Manifest Technologies has created the NAIO™ (Neuroscience and Artificial Intelligence Optimized) platform, which enables automated integration, processing, and analysis of large, complex neuroimaging data sets. The company aims to transform therapeutic development, diagnosis, and treatment for CNS disorders by advancing the world's first AI-powered computational neuroimaging system that quantifies neural and symptom data to create and choose the right therapy for the right patient at the right time. With over $50M in NIMH grants supporting their validated science, they focus on biomarker discovery, pharmacological target validation, and patient selection for CNS clinical trials.